StockClub
PARDPoniard Pharmaceuticals, Inc.$ --
Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2010 Full YearUpdated: 12/31/2010

Revenue

attach_money
0M USD
-

Operating Income

bar_chart
-28M USD
YoY +34.9%

Net Income

verified
-30M USD
YoY +34.3%

EPS

pie_chart
-26.4USD
YoY +49.6%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2011
Full-year forecast not available

Income Statement Details

Item
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
Revenue
Cost of revenue
Gross profit
0
0
0
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
8
0
17
28
-28
Interest expense
Income before tax
Income tax expense
Net income
2
0
0
-30

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.